Skip to main content
. 2005 Aug 19;134(2):425–431. doi: 10.1017/S0950268805005005

Fig. 2.

Fig. 2

XbaI PFGE patterns of clonal group A (CgA) and ciprofloxacin-TMP–SMZ-resistant CgG isolates from the phase II study. Lanes 1 and 10, lambda ladder; lane 2, prototype CgA isolate; lanes 3–6, putative CgA isolates; lanes 7–9, ciprofloxacin-TMP–SMZ-resistant CgG isolates.